749 related articles for article (PubMed ID: 19509315)
1. The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.
Soler D; Chapman T; Yang LL; Wyant T; Egan R; Fedyk ER
J Pharmacol Exp Ther; 2009 Sep; 330(3):864-75. PubMed ID: 19509315
[TBL] [Abstract][Full Text] [Related]
2. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation.
Rott LS; Briskin MJ; Andrew DP; Berg EL; Butcher EC
J Immunol; 1996 May; 156(10):3727-36. PubMed ID: 8621908
[TBL] [Abstract][Full Text] [Related]
3. Exclusive antagonism of the α4 β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates.
Fedyk ER; Wyant T; Yang LL; Csizmadia V; Burke K; Yang H; Kadambi VJ
Inflamm Bowel Dis; 2012 Nov; 18(11):2107-19. PubMed ID: 22419649
[TBL] [Abstract][Full Text] [Related]
4. Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s.
Binder MT; Becker E; Wiendl M; Schleier L; Fuchs F; Leppkes M; Atreya R; Neufert C; Atreya I; Neurath MF; Zundler S
Inflamm Bowel Dis; 2018 May; 24(6):1237-1250. PubMed ID: 29788362
[TBL] [Abstract][Full Text] [Related]
5. Baseline levels of dynamic CD4
Allner C; Melde M; Becker E; Fuchs F; Mühl L; Klenske E; Müller L; Morgenstern N; Fietkau K; Hirschmann S; Atreya R; Atreya I; Neurath MF; Zundler S
BMC Gastroenterol; 2020 Apr; 20(1):103. PubMed ID: 32293299
[TBL] [Abstract][Full Text] [Related]
6. Blockade of αEβ7 integrin suppresses accumulation of CD8
Zundler S; Schillinger D; Fischer A; Atreya R; López-Posadas R; Watson A; Neufert C; Atreya I; Neurath MF
Gut; 2017 Nov; 66(11):1936-1948. PubMed ID: 27543429
[TBL] [Abstract][Full Text] [Related]
7. An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab.
Wyant T; Fedyk E; Abhyankar B
J Crohns Colitis; 2016 Dec; 10(12):1437-1444. PubMed ID: 27252400
[TBL] [Abstract][Full Text] [Related]
8. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease.
Lamb CA; O'Byrne S; Keir ME; Butcher EC
J Crohns Colitis; 2018 Aug; 12(suppl_2):S653-S668. PubMed ID: 29767705
[TBL] [Abstract][Full Text] [Related]
9. Vedolizumab for the treatment of inflammatory bowel disease.
Haddley K
Drugs Today (Barc); 2014 Apr; 50(4):309-19. PubMed ID: 24918648
[TBL] [Abstract][Full Text] [Related]
10. Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab.
Domenis R; Marino M; Cifù A; Scardino G; Curcio F; Fabris M
PLoS One; 2020; 15(11):e0242342. PubMed ID: 33180848
[TBL] [Abstract][Full Text] [Related]
11. Potent alpha 4 beta 1 peptide antagonists as potential anti-inflammatory agents.
Jackson DY; Quan C; Artis DR; Rawson T; Blackburn B; Struble M; Fitzgerald G; Chan K; Mullins S; Burnier JP; Fairbrother WJ; Clark K; Berisini M; Chui H; Renz M; Jones S; Fong S
J Med Chem; 1997 Oct; 40(21):3359-68. PubMed ID: 9341911
[TBL] [Abstract][Full Text] [Related]
12. Antagonizing the α4β1 integrin, but not α4β7, inhibits leukocytic infiltration of the central nervous system in rhesus monkey experimental autoimmune encephalomyelitis.
Haanstra KG; Hofman SO; Lopes Estêvão DM; Blezer EL; Bauer J; Yang LL; Wyant T; Csizmadia V; 't Hart BA; Fedyk ER
J Immunol; 2013 Mar; 190(5):1961-73. PubMed ID: 23365083
[TBL] [Abstract][Full Text] [Related]
13. Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism.
Schweighoffer T; Tanaka Y; Tidswell M; Erle DJ; Horgan KJ; Luce GE; Lazarovits AI; Buck D; Shaw S
J Immunol; 1993 Jul; 151(2):717-29. PubMed ID: 7687621
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of mucosal addressin cell adhesion molecule 1 in the duodenum of patients with active celiac disease is associated with depletion of integrin alpha4beta7-positive T cells in blood.
Di Sabatino A; Rovedatti L; Rosado MM; Carsetti R; Corazza GR; MacDonald TT
Hum Pathol; 2009 May; 40(5):699-704. PubMed ID: 19157500
[TBL] [Abstract][Full Text] [Related]
15. Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B; Kopylov U; Yavzori M; Fudim E; Picard O; Lahat A; Coscas D; Waterman M; Haj-Natour O; Orbach-Zingboim N; Mao R; Chen M; Chowers Y; Eliakim R; Ben-Horin S
Clin Gastroenterol Hepatol; 2018 May; 16(5):697-705.e7. PubMed ID: 29223444
[TBL] [Abstract][Full Text] [Related]
16. Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing.
Schleier L; Wiendl M; Heidbreder K; Binder MT; Atreya R; Rath T; Becker E; Schulz-Kuhnt A; Stahl A; Schulze LL; Ullrich K; Merz SF; Bornemann L; Gunzer M; Watson AJM; Neufert C; Atreya I; Neurath MF; Zundler S
Gut; 2020 Feb; 69(2):252-263. PubMed ID: 31092589
[TBL] [Abstract][Full Text] [Related]
17. Expression of a novel integrin beta 1 chain epitope and anti-beta 1 antibody-mediated enhancement of fibronectin binding are dependent on the stage of T cell differentiation.
Wadsworth SA; Chang AC; Hong MJ; Halvorson MJ; Otto S; Coligan JE
J Immunol; 1995 Mar; 154(5):2125-33. PubMed ID: 7532661
[TBL] [Abstract][Full Text] [Related]
18. Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype.
Milch C; Wyant T; Xu J; Parikh A; Kent W; Fox I; Berger J
J Neuroimmunol; 2013 Nov; 264(1-2):123-6. PubMed ID: 24067534
[TBL] [Abstract][Full Text] [Related]
19. The role of alpha 4 integrins in lung pathophysiology.
Lobb RR; Pepinsky B; Leone DR; Abraham WM
Eur Respir J Suppl; 1996 Aug; 22():104s-108s. PubMed ID: 8871053
[TBL] [Abstract][Full Text] [Related]
20. Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.
MacKenzie WM; Hoskin DW; Blay J
Exp Cell Res; 2002 May; 276(1):90-100. PubMed ID: 11978011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
